Management Team
Fred Khosravi – President & CEO
Fred Khosravi is a Silicon Valley medical device entrepreneur who has co-founded eight companies, including EndoTex, Embolic Protection, Inc. (EPI), both acquired by Boston Scientific Corporation and Confluent Surgical, acquired by Tyco Healthcare. Additionally, he is the managing director of a medical device incubator called Incept. In addition to Confluent, EPI, and AccessClosure, Incept has spawned several other novel device companies including Sadra, SquareOne and iTherapeutix, where Fred serves as co-founder and Director/Chairman. Fred also served on the boards of Kerberos before its acquisition by FoxHollow Technologies and Advanced Stent Technologies, prior to its acquisition by Boston Scientific. Prior to his entrepreneurial career, Fred held management positions at Focal, Inc., Alcon Surgical and Guidant. At Guidant, he led the initial design and development of the MultiLink stent. Fred has authored or co-authored over 40 issued or filed patent applications. He holds a B.S. in mechanical engineering, and graduated summa cum laude, obtaining a M.S. in mechanical engineering from Tennessee Tech University.
Leslie Trigg – Chief Business Officer
Prior to joining AccessClosure, Leslie Trigg was Vice President of Marketing for FoxHollow Technologies where she helped build and manage a high-growth commercial organization which eventually led to a successful IPO. Prior to joining FoxHollow, Leslie was Business Unit Director at Cytyc Corporation following its acquisition of Pro-Duct Health, a breast cancer diagnostic company where she served as Director of Market Development. Leslie started her medical device career at Guidant in global and domestic marketing roles for vascular intervention products. Leslie holds a B.S. from Northwestern University and an MBA from University of California at Berkeley.
John J. Buckley – Chief Financial Officer
Prior to joining AccessClosure, John J. Buckley was CFO at Acologix, Inc., a biotechnology company focused on osteo-renal diseases, where he was responsible for all finance and accounting functions, corporate planning, tax, treasury operation, corporate development and risk management. Prior to Acologix, John was a Partner with JWB Partners, CFO of The Dr. Spock Company and was with Ernst & Young LLP most recently as a Partner and as the Director of the Pacific Northwest Life Science Practice. John received his B.B.A. in accounting from the
Jim Fortune – Chief Operating Officer
Jim has more than 25 years of operating experience with both public and private companies across the medical device industry. Prior to joining AccessClosure, Jim held COO positions with Confluent Surgical (acquired by Tyco Healthcare) and Intrinsic Therapeutics. He also spent 17 years in various senior management roles with Johnson & Johnson's orthopedic and neurosurgical business units. Jim has a B.S. in mechanical engineering from Renssalaer Polytechnic Institute.
Brian Armijo – Vice President, Operations
Prior to joining AccessClosure, Brian Armijo was the Vice President of Operations for Boston Scientific, Vascular Protection. There he was brought in at the early stages of teh BSC acquisition of Embolic Protection, Inc. (EPI) where he successfully built and led the operations organization. Brian's previous roles in medical startups include: Director of Operations at Quanam Medical (through BSC acquisition), Director of Manufacturing at Somnus Medical, and finally Manager of Manufacturing at Arthrocare Corporation. Brian learned much of his craft through various technical leadership roles in the Manufacturing Management Program (MMP) at General Electric. He holds a dual degree from Brown University - a B.S. in electrical engineering-control systems and a B.A. in comparative literature, Spanish.
Susan Aloyan – Vice President, Regulatory Affairs
Susan Aloyan brings over 20 years of experience in domestic and international regulatory affairs to the AccessClosure executive team. Susan was previously the Vice President of Regulatory Affairs for Conceptus and helped bring numerous first in-category devices to market. Prior to joining Conceptus, Susan served as Corporate Director, Regulatory Affairs, Quality Assurance and Clinical Affairs with Gynecare/J&J. She was responsible for approval of the Essure permanent birth control device, as well as Gynecare’s ThermaChoice product. Susan also has been responsible for regulatory submissions at CardioGenesis Corporation and Syntex Corporation. Susan has a B.S. in management from Golden Gate University and a M.A. in organizational management from University of Phoenix.
Laura Cox – Vice President, Marketing
Laura Cox was previously with FoxHollow Technologies where she led key areas as the Director of Market Development and Senior Director of Product Development. Prior to FoxHollow, she held global and US marketing roles at Guidant Corporation in the Vascular Intervention and Cardiac Surgery business units. She began her career with Eli Lilly and Company where she held various roles in engineering, sales, and market research. She holds a B.S. in Industrial Engineering from
Mike MacKinnon – Vice President, Sales
Mike MacKinnon joined AccessClosure in October 2006. Prior to joining AccessClosure, he was an Area Director of Sales at FoxHollow Technologies. Mike has 15 years of sales experience in the high tech and medical device industries. He spent four years at StorageTek prior to FoxHollow in the Strategic Sales Division. Prior to StorageTek, Mike held various sales and sales management positions in a number of high-growth tech companies. Mike has a B.S. in business administration from the University of Massachusetts-Lowell.
Scott M. Baldwin – Vice President, Quality
Scott M. Baldwin has 35 years experience in Quality Assurance, 14 years in the medical device industry, with both small start-up and Fortune 500 companies. Prior to joining AccessClosure, Scott was Director of Quality Assurance at Volcano Therapeutics, Inc. He was Director of Quality Assurance at Orquest, Inc. for three years prior to that. Scott has a B.S. in Quality Engineering from
Andy Uchida – Vice President, Engineering
Andy Uchida brings over 10 years of experience in medical device operations and research and development roles. Most recently, Andy was a Senior Director of Research and Development at FoxHollow Technologies where he and his team were responsible for the launch of several product line enhancements. Prior to joining FoxHollow, Andy was a Senior Manager of Research and Development at ORATEC Interventions in the spine products group. Prior to his medical device experience, Andy held systems engineering and research and development positions in the semiconductor and electronics industries. Andy holds a B.S. in mechanical engineering from
